Shanghai Fosun Pharmaceutical Development

Fosun Pharma is a leading global innovation-driven healthcare group based in China, with a business spanning pharmaceutical manufacturing, R&D, medical devices, and healthcare services. Founded in 1994, the company has established a robust R&D ecosystem focusing on oncology, immunology, and infectious diseases. It is well-known for its strategic partnerships, including the distribution of the BioNTech COVID-19 vaccine in Greater China and the development of CAR-T therapies through its joint venture, Fosun Kite. The company operates a diverse pipeline of innovative small molecules, biologics, and cell therapies, supported by a global manufacturing and commercialization network. Fosun Pharma is committed to addressing unmet medical needs through its "4IN" strategy of Innovation, Internationalization, Integration, and Intelligentization.